Drug interactions
Efgartigimod alfa + Rituximab
Severity: Moderate
Efgartigimod alfa and Rituximab: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Efgartigimod blocks FcRn and lowers IgG, which may reduce exposure to IgG-based monoclonal antibodies such as rituximab. Rituximab's effect might therefore be diminished.
What this interaction means in plain words
Efgartigimod alfa and Rituximab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Efgartigimod alfa belongs to Miscellaneous; Rituximab belongs to Musculoskeletal.
Why it happens
FcRn blockade reduces IgG recycling and increases clearance of rituximab; this is not receptor binding competition in the usual sense.
What to do
Monitor for reduced rituximab efficacy, and consider timing rituximab dosing away from efgartigimod cycles. If rituximab is essential long term, review efgartigimod use.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Efgartigimod alfa and Rituximab, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Rituximab
Other interactions of Efgartigimod alfa
- Adalimumab + Efgartigimod alfa Moderate
- Ado-trastuzumab + Efgartigimod alfa Moderate
- Basiliximab + Efgartigimod alfa Moderate
- Bevacizumab + Efgartigimod alfa Moderate
- Brentuximab + Efgartigimod alfa Moderate
- Denosumab + Efgartigimod alfa Moderate
Frequently asked questions
Can I take Efgartigimod alfa with Rituximab?
MediHelp rates the interaction as moderate. Efgartigimod alfa and Rituximab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efgartigimod blocks FcRn and lowers IgG, which may reduce exposure to IgG-based monoclonal antibodies such as rituximab. Rituximab's effect might therefore be diminished.
How serious is the interaction between Efgartigimod alfa and Rituximab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for reduced rituximab efficacy, and consider timing rituximab dosing away from efgartigimod cycles. If rituximab is essential long term, review efgartigimod use.
What other medicines interact with Rituximab?
MediHelp also lists interactions of Rituximab with, for example, Adenovirus types 4 and 7 live, Baricitinib, Certolizumab pegol. The full list is on the Rituximab page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
